C-reactive protein, risk of and survival after cancer - secondary publication;C-reaktivt protein, risiko for og overlevelse efter cancer - sekundærpublikation

Ugeskrift for Laeger

Volumn 171, Issue 48, 2009, Pages

  Allin, Kristine H ^a   Bojesen, Stig E ^a   Nordestgaar, Børge G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TUMOR MARKER;

ARTICLE; BLOOD; COHORT ANALYSIS; COLORECTAL TUMOR; DENMARK; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; MALE; MORTALITY; NEOPLASM; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

C-REACTIVE PROTEIN; COHORT STUDIES; COLORECTAL NEOPLASMS; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 77954940802     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Siemes C, Visser LE, Coebergh JW et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 2006;24:5216-22.
2. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Commun Health 2007;61:824-33.
3. Erlinger TP, Platz EA, Rifai N et al. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291:585-90.
4. Heikkila K, Harris R, Lowe G et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 2009;20:15-26.
5. Il'yasova D, Colbert LH, Harris TB et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomark Prev 2005;14:2413-18.
6. Tsilidis KK, Branchini C, Guallar E et al. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 2008;123:1133-40.
7. Zhang SM, Buring JE, Lee IM et al. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 2005;142:425-32.
8. Zhang SM, Lin J, Cook NR et al. C-reactive protein and risk of breast cancer. J Natl Cancer Inst 2007;99:890-4.
9. Heikkila K, Ebrahim S, Rumley A et al. Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study. Cancer Epidemiol Biomarkers Prev 2007;16:1155-9.
10. Schnohr P, Jensen JS, Scharling H et al. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. Eur Heart J 2002;23:620-6.